| Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 121-130, 2019 | 2322 | 2019 |
| Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ... The Lancet 391 (10117), 219-229, 2018 | 939 | 2018 |
| V Diretriz da Sociedade Brasileira de Cardiologia sobre tratamento do infarto agudo do miocárdio com supradesnível do segmento ST LS Piegas, A Timerman, GS Feitosa, JC Nicolau, LAP Mattos, ... Arquivos brasileiros de cardiologia 105, 1-121, 2015 | 595 | 2015 |
| Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial P Ponikowski, BA Kirwan, SD Anker, T McDonagh, M Dorobantu, ... The Lancet 396 (10266), 1895-1904, 2020 | 591 | 2020 |
| Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 131-138, 2019 | 543 | 2019 |
| Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial SJ Connolly, JW Eikelboom, J Bosch, G Dagenais, L Dyal, F Lanas, ... The Lancet 391 (10117), 205-218, 2018 | 405 | 2018 |
| I Diretriz brasileira de prevenção cardiovascular AF Simão, DB Precoma, JP Andrade, H Correa, JFK Saraiva, ... Arquivos brasileiros de cardiologia 101, 1-63, 2013 | 355 | 2013 |
| Atualização da diretriz de prevenção cardiovascular da Sociedade Brasileira de Cardiologia-2019 DB Précoma, GMM Oliveira, AF Simão, OP Dutra, OR Coelho, MCO Izar, ... Arquivos Brasileiros de Cardiologia 113, 787-891, 2019 | 324 | 2019 |
| Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial PJ Devereaux, E Duceppe, G Guyatt, V Tandon, R Rodseth, BM Biccard, ... The Lancet 391 (10137), 2325-2334, 2018 | 305 | 2018 |
| Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ... The lancet Diabetes & endocrinology 7 (8), 618-628, 2019 | 259 | 2019 |
| Updated cardiovascular prevention guideline of the Brazilian Society of Cardiology-2019 DB Precoma, GMM Oliveira, AF Simao, OP Dutra, OR Coelho, MCO Izar, ... Arquivos brasileiros de cardiologia 113, 787-891, 2019 | 250 | 2019 |
| Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo … DL Bhatt, PG Steg, SR Mehta, LA Leiter, T Simon, K Fox, C Held, ... The Lancet 394 (10204), 1169-1180, 2019 | 204 | 2019 |
| Rivaroxaban in patients with atrial fibrillation and a bioprosthetic mitral valve HP Guimarães, RD Lopes, PGM de Barros e Silva, IL Liporace, ... New England Journal of Medicine 383 (22), 2117-2126, 2020 | 195 | 2020 |
| Alirocumab reduces total nonfatal cardiovascular and fatal events: the ODYSSEY OUTCOMES trial M Szarek, HD White, GG Schwartz, M Alings, DL Bhatt, VA Bittner, ... Journal of the American College of Cardiology 73 (4), 387-396, 2019 | 194 | 2019 |
| Socioeconomic status: the missing link between obesity and diabetes mellitus? A Volaco, AM Cavalcanti, DB Précoma Current diabetes reviews 14 (4), 321-326, 2018 | 181 | 2018 |
| Cause of death and predictors of all‐cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: data from ROCKET AF SD Pokorney, JP Piccini, SR Stevens, MR Patel, KS Pieper, JL Halperin, ... Journal of the American Heart Association 5 (3), e002197, 2016 | 156 | 2016 |
| III Diretriz sobre tratamento do infarto agudo do miocárdio LS Piegas, A Timerman, JC Nicolau, LA Mattos, JM Rossi Neto, ... Arq. bras. cardiol, 1-86, 2004 | 154 | 2004 |
| Diretrizes da Sociedade Brasileira de Cardiologia sobre angina instável e infarto agudo do miocárdio sem supradesnível do segmento ST (II Edição, 2007)-Atualização 2013/2014 JC Nicolau, A Timerman, JA Marin-Neto, LS Piegas, C Barbosa, A Franci, ... Arquivos brasileiros de cardiologia 102, 01-75, 2014 | 123 | 2014 |
| Diretrizes da Sociedade Brasileira de Cardiologia sobre angina instável e infarto agudo do miocárdio sem supradesnível do segmento ST–2021 JC Nicolau, GS Feitosa Filho, JL Petriz, RHM Furtado, DB Précoma, ... Arquivos brasileiros de cardiologia 117, 181-264, 2021 | 69 | 2021 |
| I Brazilian guidelines on cardiovascular prevention AF Simão, DB Precoma, JP Andrade, H Correa Filho, JFK Saraiva, ... Arquivos brasileiros de cardiologia, 2013 | 67 | 2013 |
